Ocugen Inc
Change company Symbol lookup
Select an option...
OCGN Ocugen Inc
V Visa Inc
PG Procter & Gamble Co
TOMZ TOMI Environmental Solutions Inc
GDXD MicroSectors? Gold Miners -3X Inverse Leveraged ETNs
CWK Cushman & Wakefield PLC
NAUT Nautilus Biotechnology Inc
ZSANQ Zosano Pharma Corp
CHX ChampionX Corp
UTZ UTZ Brands Inc
Go

Health Care : Biotechnology | Small Cap Growth
Company profile

Ocugen, Inc. is a biopharmaceutical company focused on developing gene therapies to cure blindness diseases and developing vaccine for COVID-19. The Company's technology pipeline includes: COVID-19 Vaccine (0.5), Modifier Gene Therapy Platform and Novel Biologic Therapies for Retinal Diseases. COVID-19 Vaccine candidate is focused on developing, manufacturing and commercializing COVAXIN for the prevention of COVID-19 in humans in the Ocugen Covaxin Territory. COVAXIN is a whole-virion inactivated COVID-19 vaccine candidate and is formulated with the inactivated SARS-CoV-2 virus. The Modifier Gene Therapy platform is designed for retinal diseases, including retinitis pigmentosa (RP), leber congenital amaurosis (LCA) and dry age-related macular degeneration (AMD). It is developing OCU200, a biologic product candidate to treat diabetic macular edema (DME), diabetic retinopathy (DR) and wet AMD. OCU400, its first product candidate being developed with its modifier gene therapy platform.

Closing Price
$2.68
Day's Change
-0.15 (-5.30%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.95
Day's Low
2.67
Volume
(Heavy Day)
Volume:
6,695,311

10-day average volume:
5,033,722
6,695,311
  • Prev Close
    2.83
  • Today's Open
    2.86
  • Day's Range
    2.67-2.95
  • Avg Vol (10-day)
    5.0M
  • Last (time)
    4:00p ET 08/11/22
  • Last (size)
    1
  • 52-Wk Range
    1.67 - 17.65
    LowHigh
  • (11/03/21 - 05/12/22)
    60.48%
  • 110.5%
  • Market Cap
    580.4M
  • Shares Outstanding
    216.6M
  • -0.31
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 4.3
  • 36.18
  • (% of float 07/29/22)
    26.24

Latest News

August 11, 2022
5:12 pm ET
MarketWatch
August 10, 2022
5:12 pm ET
MarketWatch
August 09, 2022
5:12 pm ET
MarketWatch
August 08, 2022
5:12 pm ET
MarketWatch
August 05, 2022
5:12 pm ET
MarketWatch
8:03 am ET
Globe Newswire
August 04, 2022
5:12 pm ET
MarketWatch
August 03, 2022
5:12 pm ET
MarketWatch
August 02, 2022
5:12 pm ET
MarketWatch
August 01, 2022
5:12 pm ET
MarketWatch
July 29, 2022
5:12 pm ET
MarketWatch
7:30 am ET
Globe Newswire
July 28, 2022
5:12 pm ET
MarketWatch
July 27, 2022
5:12 pm ET
MarketWatch
July 26, 2022
5:12 pm ET
MarketWatch
July 25, 2022
5:12 pm ET
MarketWatch
July 22, 2022
5:12 pm ET
MarketWatch
July 21, 2022
5:12 pm ET
MarketWatch
July 20, 2022
5:12 pm ET
MarketWatch
July 15, 2022
5:12 pm ET
MarketWatch
July 14, 2022
5:12 pm ET
MarketWatch
July 13, 2022
5:14 pm ET
MarketWatch
July 12, 2022
5:16 pm ET
MarketWatch
July 11, 2022
5:12 pm ET
MarketWatch
July 08, 2022
5:12 pm ET
MarketWatch
July 07, 2022
5:12 pm ET
MarketWatch
July 06, 2022
5:12 pm ET
MarketWatch
July 05, 2022
5:12 pm ET
MarketWatch
July 01, 2022
5:12 pm ET
MarketWatch
June 30, 2022
5:12 pm ET
MarketWatch
June 29, 2022
5:12 pm ET
MarketWatch
10:30 am ET
PR Newswire
June 28, 2022
5:12 pm ET
MarketWatch
June 27, 2022
5:12 pm ET
MarketWatch
June 24, 2022
5:12 pm ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.